Tweet
September 16, 2009 : Last updated 06:57 pm
GPO delays flu vaccine testing after guinea pig infection
The Government Pharmaceutical Organisation (GPO) will decide next Wednesday whether to delay the first phase of clinical trials of a vaccine against a new strain of typeA (H1N1) influenza discovered after a test with guinea pigs found one had an infection in its lungs.
The GPO had planned to run its first clinical vaccine trial against the flu virus on September 21. However, after finding an infection during an animal trial, GPO decided to put off its human trials for another three days.
The Nation
GPO delays flu vaccine testing after guinea pig infection
The Government Pharmaceutical Organisation (GPO) will decide next Wednesday whether to delay the first phase of clinical trials of a vaccine against a new strain of typeA (H1N1) influenza discovered after a test with guinea pigs found one had an infection in its lungs.
The GPO had planned to run its first clinical vaccine trial against the flu virus on September 21. However, after finding an infection during an animal trial, GPO decided to put off its human trials for another three days.
The Nation
